These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 21080875

  • 1. Loss of Raf-1 kinase inhibitory protein in pancreatic ductal adenocarcinoma.
    Kim HS, Kim GY, Lim SJ, Kim YW.
    Pathology; 2010 Dec; 42(7):655-60. PubMed ID: 21080875
    [Abstract] [Full Text] [Related]

  • 2. L1 Cell adhesion molecule (L1CAM) expression at the cancer invasive front is a novel prognostic marker of pancreatic ductal adenocarcinoma.
    Tsutsumi S, Morohashi S, Kudo Y, Akasaka H, Ogasawara H, Ono M, Takasugi K, Ishido K, Hakamada K, Kijima H.
    J Surg Oncol; 2011 Jun 01; 103(7):669-73. PubMed ID: 21360711
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the clinical significance of focal adhesion kinase and SRC expression in human pancreatic ductal adenocarcinoma.
    Chatzizacharias NA, Giaginis C, Zizi-Serbetzoglou D, Kouraklis GP, Karatzas G, Theocharis SE.
    Pancreas; 2010 Aug 01; 39(6):930-6. PubMed ID: 20431421
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer.
    Fu Z, Kitagawa Y, Shen R, Shah R, Mehra R, Rhodes D, Keller PJ, Mizokami A, Dunn R, Chinnaiyan AM, Yao Z, Keller ET.
    Prostate; 2006 Feb 15; 66(3):248-56. PubMed ID: 16175585
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Expression of hypoxia-inducible factor-1 alpha and associated proteins in pancreatic ductal adenocarcinoma and their impact on prognosis.
    Sun HC, Qiu ZJ, Liu J, Sun J, Jiang T, Huang KJ, Yao M, Huang C.
    Int J Oncol; 2007 Jun 15; 30(6):1359-67. PubMed ID: 17487356
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prognostic significance of immunohistochemical RhoA expression on survival in pancreatic ductal adenocarcinoma: a high-throughput analysis.
    Dittert DD, Kielisch C, Alldinger I, Zietz C, Meyer W, Dobrowolski F, Saeger HD, Baretton GB.
    Hum Pathol; 2008 Jul 15; 39(7):1002-10. PubMed ID: 18495213
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: direct lymph node invasion has similar survival to node-negative disease.
    Pai RK, Beck AH, Mitchem J, Linehan DC, Chang DT, Norton JA, Pai RK.
    Am J Surg Pathol; 2011 Feb 15; 35(2):228-34. PubMed ID: 21263243
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inverse association between Raf Kinase Inhibitory Protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients: implications for clinical outcome.
    Chatterjee D, Sabo E, Tavares R, Resnick MB.
    Clin Cancer Res; 2008 May 15; 14(10):2994-3001. PubMed ID: 18483365
    [Abstract] [Full Text] [Related]

  • 15. Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma.
    Liang JJ, Wang H, Rashid A, Tan TH, Hwang RF, Hamilton SR, Abbruzzese JL, Evans DB, Wang H.
    Clin Cancer Res; 2008 Nov 01; 14(21):7043-9. PubMed ID: 18981001
    [Abstract] [Full Text] [Related]

  • 16. Clinicopathological significance of galectin-3 expression in ductal adenocarcinoma of the pancreas.
    Shimamura T, Sakamoto M, Ino Y, Shimada K, Kosuge T, Sato Y, Tanaka K, Sekihara H, Hirohashi S.
    Clin Cancer Res; 2002 Aug 01; 8(8):2570-5. PubMed ID: 12171885
    [Abstract] [Full Text] [Related]

  • 17. SPARC mRNA expression as a prognostic marker for pancreatic adenocarcinoma patients.
    Miyoshi K, Sato N, Ohuchida K, Mizumoto K, Tanaka M.
    Anticancer Res; 2010 Mar 01; 30(3):867-71. PubMed ID: 20393008
    [Abstract] [Full Text] [Related]

  • 18. Epidermal growth factor receptor expression in human pancreatic cancer: Significance for liver metastasis.
    Tobita K, Kijima H, Dowaki S, Kashiwagi H, Ohtani Y, Oida Y, Yamazaki H, Nakamura M, Ueyama Y, Tanaka M, Inokuchi S, Makuuchi H.
    Int J Mol Med; 2003 Mar 01; 11(3):305-9. PubMed ID: 12579331
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas.
    Ikenaga N, Ohuchida K, Mizumoto K, Yu J, Kayashima T, Hayashi A, Nakata K, Tanaka M.
    Hum Pathol; 2010 Oct 01; 41(10):1466-74. PubMed ID: 20619441
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.